The benchtop clinical chemistry analyzers market size is estimated to be USD 786.3 million in 2021 and is expected to witness a CAGR of 8.65% during the forecast period 2023-2033. The rising interest in modular automation, increasing usage of robotics and automation, implementation of software, continuous improvements in analytical laboratory automation, rapid advancements in a number of diagnosis-related sectors, and global market expansions within developing nations are factors contributing to the market growth. However, increasing demand for significant capital expenditures is expected to hinder the growth.

Segmentation

By Test

Based on test, the market is segregated into electrolyte panel, renal profile, thyroid function panel, liver panel, specialty chemicals, basic metabolic panel, and lipid profile. In 2022, the basic metabolic panel segment held the highest market share owing to growing significance and knowledge of point-of-care diagnostics.

By Type

On the basis of type, the market is bifurcated into manual analyzer and fully automatic analyzer. In 2022, the fully automatic analyzer segment held the highest market share due to automated cleaning, absolute self-checking capability, modern technology, program that is capable of multitasking, internal cooling, and auto adjustment.

By Product

Based on product, the market is divided into consumables and analyzers & reagents. In 2022, the reagents segment held the highest market share owing to the large variety of reagents are available on the market to meet various needs.

By End User

On the basis of end user, the market is categorized into academic research institutes, diagnostic centers, and others. In 2022, the diagnostic centers segment held the highest market share due to scientific discovery coupled with an increase in the detection of numerous lifestyle diseases in diagnostic centers, effective diagnostic techniques and enabling infrastructure enable, and various significant technical advancements.

Regional Markets

In 2022, North America region accounted for the highest revenue in the benchtop clinical chemistry analyzers market and is expected to maintain its dominance during the forecast period. This is attributed to the greater adherence to practice recommendations made available by healthcare groups and the government’s promoting efforts. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the existence of unrealized potential, a rise in international players’ expenditure in R&D.

Competitor Insights

Some of the key players operating in the benchtop clinical chemistry analyzers market are AGD Biomedicals Pvt. Ltd. (India), Balio Diagnostics (France), Beckman Coulter (Subsidiary of Danaher Corporation) (US), Biochemical Systems International S.p.A. (Italy), DiaSys Diagnostic Systems GmbH (Germany), EKF Diagnostics (Germany), Elitech Group (France), F. Hoffmann-La Roche Ltd. (Switzerland), Horiba, Ltd. (Japan), Medica Corporation (US), Mindray Medical International Limited (China), Randox Laboratories Ltd. (United Kingdom), Siemens AG (Germany), Thermo Fisher Scientific Inc.(US), and Wiener lab Group (Argentina).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including test, type, product, and end user from 2023 to 2033.

Report Scope:

Segmentation: Benchtop Clinical Chemistry Analyzers Market Report 2022 – 2033

Test (Revenue, USD Million), 2022 – 2033

• Electrolyte Panel
• Renal Profile
• Thyroid Function Panel
• Liver Panel
• Specialty Chemicals
• Basic Metabolic Panel
• Lipid Profile

Type (Revenue, USD Million), 2022 – 2033

• Decentralized
• Centralized

Product (Revenue, USD Million), 2022 – 2033

• Consumables
• Analyzers
• Reagents

End User (Revenue, USD Million), 2022 – 2033

• Academic Research Institutes
• Diagnostic Centers
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA